Siemens Healthineers to Improve Oncology, Cardiovascular and Neurovascular Care

Siemens Healthineers and University Hospitals (UH) build on their 40-year clinical and research collaboration with a new 10-year agreement. This partnership aims to improve the oncology, cardiovascular, and neurovascular care for patients in Ohio. 
 
Siemens and UH also hope to advance treatments for those with Alzheimer’s disease, treat patients with advanced forms of certain cancers, and develop new magnetic resonance (MR) technologies using diagnostics and therapeutics (theranostics).
 
David Pacitti, president and head of the Americas at Siemens Healthineers commented: “Siemens Healthineers is proud to build on its decades-long relationship with University Hospitals through this new strategic alliance, which will not only dramatically impact patients facing serious medical conditions in Ohio, but also explore and define new ways to improve patient health.“
 
“University Hospitals shares its excitement in expanding its ongoing collaborative relationship with Siemens Healthineers, which has resulted in important improvements in magnetic resonance imaging. We now anticipate the growing benefits from extending the latest technology innovation to our northern Ohio community,” said Paul Hinchey, CEO of University Hospitals.  
 
The UH Harrington Heart & Vascular Institute will install the photon-counting CT scanner and the new dual-source CT scanner to improve cardiovascular services. This was one of the first healthcare facilities to co-locate an MR scanner, CT scanner, and robotically operated cardiac catheterization laboratory with surgical capabilities in the same suite. Adding this machine builds on a UH and Siemens agreement from 2019. With this new alliance, UH will gain angiography systems that provide clear image quality and ultra-low patient radiation doses for image-guided cardiology interventions.
 
In working with the Radiology department of UH and its academic affiliate, Case Western Reserve University, Siemens will develop novel technologies, emphasizing MR. New research will partially involve the company’s 0.55T mid-field scanner. 
 
UH Radiology will purchase positron emission tomography (PET)/CT scanners and a comprehensive portfolio of MR scanners, including 1.5-tesla and 3T scanners to improve its neurology-related care.  The PET/CT scanners will help detect amyloid plaques for those who might have Alzheimer’s and MR scanners will allow UH to monitor treatments with emerging therapeutic drugs. UH will also install an angiography system for interventional neuro procedures and stroke treatment.
 
UH’s Cleveland Medical Center will deploy PET/CT scanners for cancer care at UH Seidman Cancer Center. This technology can identify diseases, and support the practice of theranostics, which enables clinicians to diagnose some forms of cancer with one radiopharmaceutical and treat the disease with a similar therapeutic agent. Adding Siemens Healthineers CT scanners at UH Cleveland Medical Center, and angiography systems for interventional radiology will enable efficient diagnosis and focused treatment by targeted ablations and delivery of therapy agents.